Quantcast

Latest Institute for Quality and Efficiency Stories

2013-07-25 10:08:59

Now proof of minor added benefit in severe cases or recurrences of Clostridium difficile infections In the commenting procedure on early benefit assessment pursuant to the German Act on the Reform of the Market for Medicinal Products (AMNOG), under certain circumstances drug manufacturers may submit to the Federal Joint Committee (G-BA) additional documents for dossiers. The Institute for Quality and Efficiency in Health Care (IQWiG) has now assessed such additional information for two...

2010-01-07 17:46:51

Insufficient trials -- no conclusions possible on diabetes-related diseases Contrary to the widely-held belief, there is no proof that non-insulin-dependent patients with type 2 diabetes benefit from glucose self-monitoring. Moreover, it remains unclear whether an additional benefit is displayed by the blood test compared to the urine test or vice versa, in other words, whether one or other of the tests might offer an advantage to patients. The current data are quantitatively and...

2009-12-18 14:18:22

Long-term research is lacking "“ potential harm remains unclear "“ valid studies are urgently needed for growing and developing children and adolescents Due to a lack of suitable studies, it remains unclear whether children and adolescents with type 1 diabetes benefit more or less from long-term treatment with rapid-acting insulin analogues than with short-acting human insulin. Certainly, there is no proof of additional benefit from the available results from clinical trials of...

2009-11-24 17:30:41

IQWiG presents its final report on pediatric oncological care -- still insufficient research into quality of life, pain and long-term consequences Internationally viewed, medical care in Germany for children with cancer is very good as far as survival is concerned. However, other aspects, such as quality of life, pain, and long-term consequences of the disease are still insufficiently investigated in studies. This is the conclusion of the Institute for Quality and Efficiency in Health Care...

2009-11-24 17:24:48

However, bupropion XL and mirtazapine can benefit people suffering from depression There is no scientific proof that people suffering from depression can benefit from taking reboxetine. However, clinical trials do provide proof of benefit of bupropion XL and mirtazapine: both agents can alleviate symptoms. This is the conclusion of the final report of the Institute for Quality and Efficiency in Health Care (IQWiG) published on 24 November 2009. The final evaluation of reboxetine and...

2009-11-24 17:15:38

Manufacturers who conceal data are harming patients and hindering the work of IQWiG and the G-BA Today the Institute for Quality and Efficiency in Health Care (IQWiG) is calling for registration and publication of the results of all clinical trials to be made obligatory. The German Federal Government must push for a mandatory regulation to be implemented at EU level; in the USA this obligation has been in force since 2008. This has been brought to a head by the publication of the final report...

2009-10-28 15:29:09

Not all data from studies carried out to date have been made available There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine. This is the conclusion in the final report that the Institute for Quality and Efficiency in Health Care (IQWiG) published in September 2009. The report is part of a broader commission awarded by the Federal Joint Committee (G-BA) to assess both drug and non-drug therapy options for...

2009-06-26 15:51:46

The risk of cancer possibly increases if patients with diabetes use the long-acting insulin analogue glargine instead of human insulin. The Institute for Quality and Efficiency in Health Care (IQWiG), in collaboration with the "Wissenschaftliches Institut der AOK" (WIdO), the research institute of the German Local Health Care Fund, analysed the data of almost 130,000 patients with diabetes in Germany who had been treated with either human insulin or the insulin analogues lispro (trade name:...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related